|
Volume 272, Number 27,
Issue of July 4, 1997
pp. 17216-17222
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Urokinase Plasminogen Activator and Gelatinases Are Associated
with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells
(Received for publication, February 3, 1997, and in revised form, April 28, 1997)
Angela
Ginestra
,
Sara
Monea
§
,
Graziano
Seghezzi
§
,
Vincenza
Dolo
,
Hideaki
Nagase
**
,
Paolo
Mignatti
§
and
M. Letizia
Vittorelli
§§
From the § Department of Cellular and Developmental
Biology, University of Palermo, Italy 90128, § Department of
Genetics and Microbiology, University of Pavia, Italy, 27100 Department of Experimental Medicine, University of L'Aquila,
Italy 67010, ** Department of Biochemistry and Molecular Biology,
University of Kansas Medical Center, Kansas City, Kansas 66160, and
§§ COBS (Centro di Oncobiologia Sperimentale),
Palermo, Italy 90128
Membrane vesicles are shed by tumor cells both
in vivo and in vitro. Although their functions
are not well understood, it has been proposed that they may play
multiple roles in tumor progression. We characterized membrane vesicles
from human HT1080 fibrosarcoma cell cultures for the presence of
proteinases involved in tumor invasion. By gelatin zymography and
Western blotting, these vesicles showed major bands corresponding to
the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A
(MMP-2) and to the MMP-9·tissue inhibitor of metalloproteinase 1 complex. Both gelatinases appeared to be associated with the vesicle
membrane. HT1080 cell vesicles also showed a strong,
plasminogen-dependent fibrinolytic activity in 125I fibrin
assays; this activity was associated with urokinase plasminogen activator, as shown by casein zymography and Western blotting. Urokinase was bound to its high affinity receptor on the vesicle membrane. Addition of plasminogen resulted in activation of the progelatinases associated with the vesicles, indicating a role of the
urokinase-plasmin system in MMP-2 and MMP-9 activation. We propose that
vesicles shed by tumor cells may provide a large membrane surface for
the activation of membrane-associated proteinases involved in
extracellular matrix degradation and tissue invasion.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. A. Merrick
The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research
Brief Funct Genomic Proteomic,
February 12, 2008;
(2008)
eln004v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Aoki, S. Jin-no, Y. Nakagawa, N. Asai, E. Arakawa, N. Tamura, T. Tamura, and T. Matsuda
Identification and Characterization of Microvesicles Secreted by 3T3-L1 Adipocytes: Redox- and Hormone-Dependent Induction of Milk Fat Globule-Epidermal Growth Factor 8-Associated Microvesicles
Endocrinology,
August 1, 2007;
148(8):
3850 - 3862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li
Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis
Clin. Cancer Res.,
June 1, 2007;
13(11):
3115 - 3124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, C.-H. Tang, Y. Kim, L. Robillard, F. Zhang, M. C. Kugler, and H. A. Chapman
Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells
J. Biol. Chem.,
February 9, 2007;
282(6):
3929 - 3939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, H. Avila, H. Wang, J. Trevino, G. E. Gallick, Y. Kitadai, T. Sasaki, and D. D. Boyd
Plasticity in Urokinase-Type Plasminogen Activator Receptor (uPAR) Display in Colon Cancer Yields Metastable Subpopulations Oscillating in Cell Surface uPAR Density--Implications in Tumor Progression
Cancer Res.,
August 15, 2006;
66(16):
7957 - 7967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Y. Shin, W. K.K. Wu, K.-M. Chu, H. P.S. Wong, E. K.Y. Lam, E. K.K. Tai, M. W.L. Koo, and C.-H. Cho
Nicotine Induces Cyclooxygenase-2 and Vascular Endothelial Growth Factor Receptor-2 in Association with Tumor-Associated Invasion and Angiogenesis in Gastric Cancer
Mol. Cancer Res.,
November 1, 2005;
3(11):
607 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bianco, E. Pravettoni, A. Colombo, U. Schenk, T. Moller, M. Matteoli, and C. Verderio
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1{beta} Release from Microglia
J. Immunol.,
June 1, 2005;
174(11):
7268 - 7277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. de Winne, E. Roseeuw, J. Pagnaer, and E. Schacht
Succinoylated Poly[N-(2- Hydroxyethyl)-L-Glutamine] Derivatives for Drug Delivery
Journal of Bioactive and Compatible Polymers,
November 1, 2004;
19(6):
439 - 452.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Gasser and J. A. Schifferli
Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis
Blood,
October 15, 2004;
104(8):
2543 - 2548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Graves, E. V. Ariztia, J. R. Navari, H. J. Matzel, M. S. Stack, and D. A. Fishman
Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles
Cancer Res.,
October 1, 2004;
64(19):
7045 - 7049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bjorklund, P. Heikkila, and E. Koivunen
Peptide Inhibition of Catalytic and Noncatalytic Activities of Matrix Metalloproteinase-9 Blocks Tumor Cell Migration and Invasion
J. Biol. Chem.,
July 9, 2004;
279(28):
29589 - 29597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Taverna, G. Ghersi, A. Ginestra, S. Rigogliuso, S. Pecorella, G. Alaimo, F. Saladino, V. Dolo, P. Dell'Era, A. Pavan, et al.
Shedding of Membrane Vesicles Mediates Fibroblast Growth Factor-2 Release from Cells
J. Biol. Chem.,
December 19, 2003;
278(51):
51911 - 51919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Boyd, S.-J. Kim, H. Wang, T. R. Jones, and G. E. Gallick
A Urokinase-Derived Peptide (A6) Increases Survival of Mice Bearing Orthotopically Grown Prostate Cancer and Reduces Lymph Node Metastasis
Am. J. Pathol.,
February 1, 2003;
162(2):
619 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Kim, H. M. Lee, T. H. Lee, C. Kang, H. K. Kleinman, and Y. S. Gho
Extracellular Membrane Vesicles from Tumor Cells Promote Angiogenesis via Sphingomyelin
Cancer Res.,
November 1, 2002;
62(21):
6312 - 6317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rosmann, D. Hahn, D. Lottaz, M.-N. Kruse, W. Stocker, and E. E. Sterchi
Activation of Human Meprin-alpha in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System
J. Biol. Chem.,
October 18, 2002;
277(43):
40650 - 40658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Taraboletti, S. D'Ascenzo, P. Borsotti, R. Giavazzi, A. Pavan, and V. Dolo
Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells
Am. J. Pathol.,
February 1, 2002;
160(2):
673 - 680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Voura, R. A. Ramjeesingh, A. M.P. Montgomery, and C.-H. Siu
Involvement of Integrin alpha vbeta 3 and Cell Adhesion Molecule L1 in Transendothelial Migration of Melanoma Cells
Mol. Biol. Cell,
September 1, 2001;
12(9):
2699 - 2710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Manna, A. Mukhopadhyay, and B. B. Aggarwal
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-{kappa}B, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
J. Immunol.,
June 15, 2000;
164(12):
6509 - 6519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mira, S. Mañes, R. A. Lacalle, G. Márquez, and C. Martínez-A
Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-9
Endocrinology,
April 1, 1999;
140(4):
1657 - 1664.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Sugiura, L. Ma, B. Sun, H. Shimada, W. E. Laug, R. C. Seeger, and Y. A. DeClerck
The Plasminogen-Plasminogen Activator (PA) System in Neuroblastoma: Role of PA Inhibitor-1 in Metastasis
Cancer Res.,
March 1, 1999;
59(6):
1327 - 1336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Allgayer, H. Wang, Y. Wang, M. M. Heiss, R. Bauer, O. Nyormoi, and D. Boyd
Transactivation of the Urokinase-type Plasminogen Activator Receptor Gene through a Novel Promoter Motif Bound with an Activator Protein-2alpha -related Factor
J. Biol. Chem.,
February 19, 1999;
274(8):
4702 - 4714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Olson, M. Toth, D. C. Gervasi, Y. Sado, Y. Ninomiya, and R. Fridman
High Affinity Binding of Latent Matrix Metalloproteinase-9 to the alpha 2(IV) Chain of Collagen IV
J. Biol. Chem.,
April 24, 1998;
273(17):
10672 - 10681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nguyen, J. Arkell, and C. J. Jackson
Active and Tissue Inhibitor of Matrix Metalloproteinase-free Gelatinase B Accumulates within Human Microvascular Endothelial Vesicles
J. Biol. Chem.,
February 27, 1998;
273(9):
5400 - 5404.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|